ProQR Therapeutics NV (PRQR) – cena akcií a novinky – Google Finance

Finance

DomovPRQR • NASDAQ

ProQR Therapeutics NV

1,74 $

22. 1., 12:39:39 GMT-5 · USD · NASDAQ · Vylúčenie

Alnylam Pharmaceuticals, Inc.

370,33 $

ALNY1,33 %

China SXT Pharmaceuticals Inc

0,091 $

SXTC0,22 %

Diginex Ltd

1,38 $

DGNX4,51 %

SMX (Security Matters) PLC

20,33 $

SMX0,86 %

ICZOOM Group Inc

1,38 $

IZM1,46 %

Star Fashion Culture Holdings Ltd

0,11 $

STFS2,61 %

Cyclerion Therapeutics Inc

1,39 $

CYCN2,96 %

Atara Biotherapeutics Inc

4,97 $

ATRA8,04 %

Estrella Immunopharma Inc

0,98 $

ESLA7,35 %

Mangoceuticals Inc

0,57 $

MGRX2,74 %

AkcieKrajina cenného papiera: USA

Predch. zatv. cena

1,64 $

Denný rozsah

1,64 $ - 1,75 $

Rozsah rokov

1,08 $ - 3,10 $

Trhová kapitalizácia

184,01 mil. USD

Priemerný objem

603,08 tis.

Cena/zisk

-

Dividendový výnos

-

Hlavná burza

NASDAQ

Novinky na trhu

pred 24 minútami

Northfield Bancorp (NASDAQ:NFBK) Sets New 52-Week High - What's Next?

MKDWELL Tech to Implement 30-for-1 Share Combination to Support Nasdaq Compliance

pred 24 minútami

First Financial Corporation Indiana (NASDAQ:THFF) Hits New 1-Year High - Time to Buy?

pred 3 hodinami

Wall Street’s Texas move gains steam as NYSE Texas hits 100-company milestone

pred 2 hodinami

Nasdaq Seeks Removal of Trading Restrictions on Bitcoin and Ethereum ETFs

pred 2 hodinami

ETFs That Could Outperform the S&P 500 Soon

Informácie

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer. Wikipedia

Generálny riaditeľ

Daniel A. de Boer

Dátum založenia

2012

Web

Zamestnanci

166

Vyhľadávanie

Vymazať vyhľadávanie

Zavrieť vyhľadávanie

Aplikácie Googlu

Hlavná ponuka